Advancing the Fight Against Cardiometabolic Disease
As a single point of access for active practitioners seeking to stay abreast on evolving science and management of cardiometabolic diseases, the Cardiometabolic Health Congress (CMHC) serves to provide the highest quality and most clinically current education available to reduce the risk of cardiometabolic disease and improve clinical outcomes.
Currently, cardiovascular disease is the leading cause of death worldwide, with over 30% (2.1 billion) of the global population suffering from high-risk factors such as obesity, dyslipidemia, and high blood pressure. Combined, diabetes, obesity, and insulin resistance are the most common causes of preventable death in the United States--representing more than 30% ($600 billion) of overall health costs.
Over 610,000 people die of heart disease in the United States every year–that accounts for 1 in every 4 deaths.
In short, the globe is facing a growing public health crisis which demands an urgent and forceful response. With over a decade of history in closely reviewing the latest clinical research and pursuing the most effective treatment options, CMHC provides a comprehensive and integrated educational opportunity for clinicians seeking to tackle this burgeoning epidemic.
We Lead. We Equip. We Fight.
Developed, organized, and led by world-renowned clinical authorities in a wide spectrum of cardiovascular and metabolic specialties, CMHC’s extensive array of educational opportunities (including live conferences, online educational activities, cardiometabolic resources and more) translate the latest clinical trials, evidence, and evolving guidelines into practical approaches for the entire multidisciplinary health care team. Through a commitment to remaining in-step with cutting edge clinical science, CMHC is dedicated to equipping clinicians from across the globe with the primary mission of combatting alarming rates of cardiometabolic disease.
First launched in October 2006 in Boston, The Cardiometabolic Health Congress has since grown to be the largest US-based, multidisciplinary conference and educational resource addressing cardiometabolic disease prevention and management. Throughout its history, CMHC has continued to expand its educational offerings, establishing the annual CMHC West: Advancing Cardiometabolic Health from East to West in 2016, launching the highly acclaimed Cardiometabolic Chronicle in 2018 (https://www.cardiometabolichealth.org/cardiometabolic-chronicle.html), and continually developing a comprehensive online education center for active clinicians.
The Cardiometabolic Health Congress is produced by Tarsus®. The acquisition of the CMHC in early 2014 expanded Tarsus' medical division, Tarsus Medical Group, to include live and online medical education offerings focused on the prevention and management of cardiometabolic diseases. Tarsus Medical Group provides a comprehensive, revolutionary collection of global events focused on valuable live and online medical education programs for healthcare practitioners of various specialties. All entities are geared at providing clinical education focused on disease prevention and management, taking into account a rapidly changing health industry.